Inflammasomes as exciting new therapeutic targets for treating diseases

Project opportunity

This Earmarked Scholarship project is aligned with a recently awarded Category 1 research grant. It offers you the opportunity to work with leading researchers and contribute to large projects of national significance.

Inflammation drives many devastating human diseases for which patients have no disease-modifying drugs. Uncontrolled inflammation drives diseases such as genetic auto-inflammation, chronic liver disease and neurodegenerative diseases. The Inflammasome Lab at IMB is defining the molecular and cellular processes of inflammation and developing new drugs to fight these diseases. We seek to unravel the secrets of inflammasomes – protein complexes at the heart of inflammation and disease – to enable the development of new drugs to treat human diseases. We are a team of award-winning researchers who enjoy a collaborative, fun approach to science. We value team diversity and multidisciplinarity, and provide a supportive lab culture for outstanding mentoring, teaching, learning, and research outcomes. We encourage applications from prospective students that belong to communities that are traditionally underrepresented in science and academia.

This PhD project will be tailored to the specific interests and career goals of the student, and will aim to either: (i) understand precisely how inflammasomes drive inflammation in genetic auto-inflammatory disease, chronic liver disease or neurodegenerative disease; OR (ii) characterise novel inflammasome inhibitors as new therapies to fight such diseases. Projects may involve techniques such as molecular cloning, cell culture, basic and advanced microscopy, immunological assays (ELISA, western blot, flow cytometry), cell death assays and/or assessment of mouse disease phenotypes. This student project will enjoy strong supervision and mentoring from Professor Schroder and her high-performing team (which include >50% postdoctoral scientists).

For more information about the Institute for Molecular Bioscience (IMB), the IMB Inflammasome Lab, or Professor Kate Schroder, please link to the following sites:

Scholarship value

As a scholarship recipient, you'll receive: 

  • living stipend of $28,854 per annum tax free (2022 rate), indexed annually
  • tuition fees covered
  • single Overseas Student Health Cover (OSHC)

Supervisor

Professor Kate Schroder

Institute for Molecular Bioscience

Email: k.schroder@imb.uq.edu.au

Preferred educational background

Your application will be assessed on a competitive basis.

We take into account your

  • previous academic record
  • publication record
  • honours and awards
  • employment history.

A working knowledge of immunology would be of benefit to someone working on this project.

The applicant will demonstrate academic achievement in the field(s) of immunology and the potential for scholastic success.

A background or knowledge of molecular cell biology and/or animal disease models is highly desirable.

Latest commencement date

If you are the successful candidate, you must commence by Research Quarter 1, 2025. You should apply at least 3 months prior to the research quarter commencement date.

If you are an international applicant, you may need to apply much earlier for visa requirements.

How to apply

You apply for this project as part of your PhD program application.

View application process